Obrien Morgan E's Form 4 filing
Anterix Inc.ATEX · filed Aug 17, 2021
- Accession no.
- 0001209191-21-052008
- Filed
- Aug 17, 2021
- Trade date
- Aug 13-16, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $282.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Obrien Morgan ECIK 0000937846 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Common Stock | SSaleDisposed | −5,000 | $56.50F1 | −$282,500 | 55,547 | Direct | |
| Aug 16, 2021 | Common Stock | FTax withholdingDisposed | −2,365 | $56.49 | −$133,598.85 | 53,182 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $56.28 to $57.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.